KALA BIO, Inc. - Common Stock, $0.001 par value per share (KALA)

CUSIP: 483119202

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / Common Stock, $0.001 par value per share
Shares outstanding
28,929,479
Total 13F shares
3,640,815
Share change
-499,985
Total reported value
$17,329,892
Price per share
$4.76
Number of holders
28
Value change
-$2,659,836
Number of buys
11
Number of sells
8

Quarterly Holders Quick Answers

What is CUSIP 483119202?
CUSIP 483119202 identifies KALA - KALA BIO, Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of KALA - KALA BIO, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Rajeev M. Shah
3/4/5
Director
class O/S missing
10,914,613
$73,564,492 17 Jun 2021
RA CAPITAL MANAGEMENT, L.P.
3/4/5
10%+ Owner
class O/S missing
7,039,613
$47,446,992 26 May 2022
Gregory Grunberg
3/4/5
Director
class O/S missing
5,451,860
$36,745,536 17 Jun 2021
BAKER BROS. ADVISORS LP
13F
Company
4.2%
1,201,894
$6,886,853 31 Mar 2025
13F
Cormorant Asset Management, LP
13F
Company
2.1%
603,027
$3,455,345 31 Mar 2025
13F
SR ONE CAPITAL MANAGEMENT, LP
13F
Company
2.1%
598,940
$3,431,926 31 Mar 2025
13F
ADAR1 Capital Management, LLC
13F 13D/G
Company
4.9%
from 13D/G
298,955
$1,713,012 31 Mar 2025
PERCEPTIVE ADVISORS LLC
13F
Company
0.96%
277,610
$1,590,705 31 Mar 2025
13F
Woodline Partners LP
13F
Company
0.89%
258,766
$1,482,729 31 Mar 2025
13F
SILVERARC CAPITAL MANAGEMENT, LLC
13F
Company
0.85%
246,079
$1,410,033 31 Mar 2025
13F
Hongming Chen
3/4/5
CHIEF SCIENTIFIC OFFICER
class O/S missing
204,515
$1,378,431 26 Oct 2021
AIGH Capital Management LLC
13F
Company
0.68%
196,350
$1,125,086 31 Mar 2025
13F
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)
13F
Company
0.59%
170,917
$979,354 31 Mar 2025
13F
VANGUARD GROUP INC
13F
Company
0.53%
152,775
$875,400 31 Mar 2025
13F
Eric Trachtenberg
3/4/5
Chief Legal Officer, Chief Compliance Officer and Secretary
mixed-class rows
88,566
mixed-class rows
$458,765 04 Jan 2024
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.19%
54,833
$314,237 31 Mar 2025
13F
READYSTATE ASSET MANAGEMENT LP
13F
Company
0.15%
42,459
$243,290 31 Mar 2025
13F
BlackRock, Inc.
13F
Company
0.07%
21,356
$122,370 31 Mar 2025
13F
Mark S. Blumenkranz
3/4/5
Director
mixed-class rows
17,517
mixed-class rows
$87,495 11 Jun 2024
Andrew I. Koven
3/4/5
Director
mixed-class rows
23,822
mixed-class rows
$68,566 15 Jun 2025
Howard B. Rosen
3/4/5
Director
mixed-class rows
21,952
mixed-class rows
$66,667 15 Jun 2025
NORTHERN TRUST CORP
13F
Company
0.04%
10,399
$59,586 31 Mar 2025
13F
Gregory D. Perry
3/4/5
Director
mixed-class rows
18,794
mixed-class rows
$53,909 15 Jun 2025
C. Daniel Myers
3/4/5
Director
mixed-class rows
15,824
mixed-class rows
$41,910 15 Jun 2025
Marjan Farid
3/4/5
Director
mixed-class rows
15,692
mixed-class rows
$41,377 15 Jun 2025
UBS Group AG
13F
Company
0.01%
3,414
$19,563 31 Mar 2025
13F
Covestor Ltd
13F
Company
0%
1,140
$7,000 31 Mar 2025
13F
MORGAN STANLEY
13F
Company
0%
972
$5,570 31 Mar 2025
13F
MAI Capital Management
13F
Company
0%
300
$1,719 31 Mar 2025
13F
Tower Research Capital LLC (TRC)
13F
Company
0%
221
$1,266 31 Mar 2025
13F
Steward Partners Investment Advisory, LLC
13F
Company
0%
120
$688 31 Mar 2025
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0%
98
$562 31 Mar 2025
13F
Cheviot Value Management, LLC
13F
Company
class O/S missing
153
$555 31 Mar 2025
13F
JPMORGAN CHASE & CO
13F
Company
0%
60
$344 31 Mar 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0%
49
$281 31 Mar 2025
13F
Legacy Wealth Managment, LLC/ID
13F
Company
0%
25
$144 31 Mar 2025
13F
CURIO WEALTH, LLC
13F
Company
0%
1
$139 31 Mar 2025
13F
Binnacle Investments Inc
13F
Company
0%
8
$46 31 Mar 2025
13F
SBI Securities Co., Ltd.
13F
Company
0%
8
$46 31 Mar 2025
13F
Parallel Advisors, LLC
13F
Company
class O/S missing
1
$6 31 Mar 2025
13F
Robert Bradley Paull
3/4/5
Director
class O/S missing
40,000
16 Jun 2022

Institutional Holders of KALA BIO, Inc. - Common Stock, $0.001 par value per share (KALA) as of Q2 2025

As of 30 Jun 2025, KALA BIO, Inc. - Common Stock, $0.001 par value per share (KALA) was held by 28 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,640,815 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, Cormorant Asset Management, LP, SR One Capital Management, LP, Woodline Partners LP, AIGH Capital Management LLC, VANGUARD GROUP INC, ADAR1 Capital Management, LLC, OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC), GEODE CAPITAL MANAGEMENT, LLC, and PERCEPTIVE ADVISORS LLC. This page lists 28 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
26
Q2 2025 holders
28
Holder diff
2
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 Value $ Q2 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .